25 research outputs found
Self-administered version of the Fabry-associated pain questionnaire for adult patients
Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers
https://deepblue.lib.umich.edu/bitstream/2027.42/138963/1/12987_2017_Article_71.pd
Lidocaine Patch (5%) in Treatment of Persistent Inguinal Postherniorrhaphy Pain:A Randomized, Double-blind, Placebo-controlled, Crossover Trial
Neuropathic pain in two-generation twins carrying the sodium channel Nav1.7 functional variant R1150W
Effects of methyl-beta-cyclodextrin on blood-brain barrier permeability in angiotensin II-induced hypertensive rats.
Changes in pain intensity between baseline and 1 month after patch application presented as SPID for capsaicin and placebo patch treatments, and the mean difference.
<p>The SPID was calculated as the difference between the baseline SPI-value and the SPI-value at 1 month after patch application. Each SPI- value contains six median values (pain assessments twice daily for three days). Values are mean (95% CI). Positive values of SPID indicate pain reduction after treatment. <i>P</i>-values indicate comparisons of SPID (capsaicin <i>vs</i>. placebo).</p><p>NRSâ=âNumerical Rating Scale (0â10), SPIDâ=âSummed pain intensity difference, SPIâ=âsummed pain intensity.</p><p>Changes in pain intensity between baseline and 1 month after patch application presented as SPID for capsaicin and placebo patch treatments, and the mean difference.</p
Baseline patient characteristics.
â <p>Mean (standard deviation).</p>âĄ<p>Median (25â75% interquartile range).</p>§<p>Pain-generating inguinal hernia operation.</p>¶<p>Pain ratings at baseline assessed at rest in the supine position, during transition from supine to standing position, and during the patientâs palpation of the point of maximum pain in the groin. Values are medians (25â75% interquartile range). Two patients who withdrew early from the study and one patient who was lost to follow-up did not report baseline pain ratings and were not included in the analyses of pain ratings.</p><p>BMIâ=âBody Mass Index, NRSâ=âNumerical Rating Scale (0â10), NSAIDsâ=âNon-steroidal Anti-inflammatory Drugs.</p><p>Baseline patient characteristics.</p
Differences in quantitative sensory assessments on the pain side from baseline to 1 month after patch application.
<p>Values are mean (95% CI)<sup>§</sup> or median (95% CI). Î valueâ=âpost-treatment minus baseline value. <i>P</i>-values indicate comparisons of Î-values (capsaicin <i>vs</i>. placebo [unpaired t-test<sup>âĄ</sup> or the Mann-Whitney test). Positive Î-values for WDT, HPT, PPT and CDT indicate increased thresholds after treatment.</p><p>WDTâ=âwarmth detection threshold, CDTâ=âcool detection threshold, HPTâ=âheat pain threshold, PPTâ=âpressure pain threshold, STHâ=âsuprathreshold heat pain perception, NRSâ=âNumerical Rating Scale (0â10).</p><p>Differences in quantitative sensory assessments on the pain side from baseline to 1 month after patch application.</p